|
[1]
|
Roth, G.A., Mensah, G.A., Johnson, C.O., Addolorato, G., Ammirati, E., Baddour, L.M., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76, 2982-3021. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Poller, W.C., Nahrendorf, M. and Swirski, F.K. (2020) Hematopoiesis and Cardiovascular Disease. Circulation Research, 126, 1061-1085. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Goldberger, A.L., Peng, C.K. and Lipsitz, L.A. (2002) What Is Physiologic Complexity and How Does It Change with Aging and Disease? Neurobiology of Aging, 23, 23-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Campisi, J. and d'Adda di Fagagna, F. (2007) Cellular Senescence: When Bad Things Happen to Good Cells. Nature Reviews Molecular Cell Biology, 8, 729-740. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Fyhrquist, F., Saijonmaa, O. and Strandberg, T. (2013) The Roles of Senescence and Telomere Shortening in Cardiovascular Disease. Nature Reviews Cardiology, 10, 274-283. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zhang, Z., Murtagh, F., Van Poucke, S., Lin, S. and Lan, P. (2017) Hierarchical Cluster Analysis in Clinical Research with Heterogeneous Study Population: Highlighting Its Visualization with R. Annals of Translational Medicine, 5, 75-75. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Solanki, A., Bhatt, L.K. and Johnston, T.P. (2018) Evolving Targets for the Treatment of Atherosclerosis. Pharmacology & Therapeutics, 187, 1-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
中国发展研究基金会. 中国发展报告2020: 中国人口老龄化的发展趋势和政策[M]. 北京: 人民出版社, 2020.
|
|
[9]
|
Fleg, J.L., Aronow, W.S. and Frishman, W.H. (2010) Cardiovascular Drug Therapy in the Elderly: Benefits and Challenges. Nature Reviews Cardiology, 8, 13-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Heidenreich, P.A., Trogdon, J.G., Khavjou, O.A., Butler, J., Dracup, K., Ezekowitz, M.D., et al. (2011) Forecasting the Future of Cardiovascular Disease in the United States. Circulation, 123, 933-944. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Childs, B.G., Durik, M., Baker, D.J. and van Deursen, J.M. (2015) Cellular Senescence in Aging and Age-Related Disease: From Mechanisms to Therapy. Nature Medicine, 21, 1424-1435. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Maehama, T. and Dixon, J.E. (1998) The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3, 4, 5-Trisphosphate. Journal of Biological Chemistry, 273, 13375-13378. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Stambolic, V., Suzuki, A., de la Pompa, J.L., Brothers, G.M., Mirtsos, C., Sasaki, T., et al. (1998) Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN. Cell, 95, 29-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., et al. (1997) PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer. Science, 275, 1943-1947. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
薛锐, 夏中元, 孟庆涛. PTEN在神经系统损伤、心血管疾病发生发展中的作用研究进展[J]. 山东医药, 2016, 56(3): 93-94.
|
|
[16]
|
Bretón-Romero, R., Kalwa, H., Lamas, S. and Michel, T. (2013) Role of PTEN in Modulation of ADP-Dependent Signaling Pathways in Vascular Endothelial Cells. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1833, 2586-2595. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
于林君, 祝善俊, 周裔忠, 等. PTEN抑制钙/钙调神经磷酸酶信号通路、负性调控血管紧张素II所致心肌细胞肥大[J]. 中华心血管病杂志, 2006(6): 541-545.
|
|
[18]
|
李勇, 杨特, 沈怡. miRNA-26a抑制ox-LDL介导的HAECs凋亡作用的机制研究[J]. 重庆医学, 2016, 45(36): 5052-5055. [Google Scholar] [CrossRef]
|
|
[19]
|
Dong, X., Yu, L., Sun, R., Cheng, Y., Cao, H., Yang, K., et al. (2012) Inhibition of PTEN Expression and Activity by Angiotensin II Induces Proliferation and Migration of Vascular Smooth Muscle Cells. Journal of Cellular Biochemistry, 114, 174-182. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ittner, A., Block, H., Reichel, C.A., Varjosalo, M., Gehart, H., Sumara, G., et al. (2012) Regulation of PTEN Activity by P38δ-Pkd1 Signaling in Neutrophils Confers Inflammatory Responses in the Lung. Journal of Experimental Medicine, 209, 2229-2246. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Shen, W.H., Balajee, A.S., Wang, J., Wu, H., Eng, C., Pandolfi, P.P., et al. (2007) Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity. Cell, 128, 157-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Fantl, W.J., Escobedo, J.A., Martin, G.A., et al. (1992) Distinct Phosphotyrosines on a Growth Factor Receptor Bind to Specific Molecules That Mediate Different Signaling Pathways. Cell, 69, 413-423.
|
|
[23]
|
Tari, A.M. and Lopez-Berestein, G. (2001) GRB2: A Pivotal Protein in Signal Transduction. Seminars in Oncology, 28, 142-147. [Google Scholar] [CrossRef]
|
|
[24]
|
Joo, J.H., Oh, H., Kim, M., An, E.J., Kim, R., Lee, S., et al. (2016) NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of Noxo1 in Colon Cancer Cells. Cancer Research, 76, 855-865. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Proctor, B.M., Ren, J., Chen, Z., Schneider, J.G., Coleman, T., Lupu, T.S., et al. (2007) Grb2 Is Required for Atherosclerotic Lesion Formation. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1361-1367. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Tong, S., Qingsong, Y.U. and Saying, D. (2019) Effects of GRB2 Gene Silencing on Lipid Deposition and Inflammatory Infiltration in Atherosclerotic rats through Inhibiting PI3K/AKT/NF-κB Signaling Pathway. Journal of Southeast University (Medical Science Edition), 38, 792-799.
|
|
[27]
|
Adams, T.E., Epa, V.C., Garrett, T.P.J. and Ward, C.W. (2000) Structure and Function of the Type 1 Insulin-Like Growth Factor Receptor. Cellular and Molecular Life Sciences, 57, 1050-1093. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
De Meyts, P. and Whittaker, J. (2002) Structural Biology of Insulin and IGF1 Receptors: Implications for Drug Design. Nature Reviews Drug Discovery, 1, 769-783. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Gallagher, E.J. and LeRoith, D. (2010) The Proliferating Role of Insulin and Insulin-Like Growth Factors in Cancer. Trends in Endocrinology & Metabolism, 21, 610-618. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Puche, J.E. and Castilla-Cortázar, I. (2012) Human Conditions of Insulin-Like Growth Factor-I (IGF-I) Deficiency. Journal of Translational Medicine, 10, ArticleNo. 224. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Onn, A., Isobe, T., Wu, W., Itasaka, S., Shintani, T., Shibuya, K., et al. (2004) Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Does Not Improve Paclitaxel Effect in an Orthotopic Mouse Model of Lung Cancer. Clinical Cancer Research, 10, 8613-8619. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Gridelli, C., Rossi, A., Maione, P., Colantuoni, G., Gaizo, F.D., Ferrara, C., et al. (2007) Erlotinib in Non-Small-Cell Lung Cancer. Expert Opinion on Pharmacotherapy, 8, 2579-2592. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Lamb, D.J., Modjtahedi, H., Plant, N.J. and Ferns, G.A.A. (2004) EGF Mediates Monocyte Chemotaxis and Macrophage Proliferation and EGF Receptor Is Expressed in Atherosclerotic Plaques. Atherosclerosis, 176, 21-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Wang, L., Huang, Z., Huang, W., et al. (2017) Inhibition of Epidermal Growth Factor Receptor Attenuates Atherosclerosis via De-Creasing Inflammation and Oxidative Stress. Scientific Reports, 8, Article No. 45917.
|